Media

ASCO Annual Meeting, June 1-5, 2018 McCormick Place, Chicago, IL https://am.asco.org/

This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Inova, Children’s National Health System, QIAGEN, Maryland Tech Council, University System of Maryland

AACR Annual Meeting 2018 Driving Innovative Cancer Science to Patient Care  April 14-18, 2018 McCormick Place North/South Chicago, Illinois http://2018-aacr.org/

Research, Development And Strategic Partnering For The Global Vaccine Industry 2-5 April 2018, Renaissance Washington DC Downtown Hotel http://www.terrapinn.com/Conference/world-vaccine-congress-washington/index.stm  

Scientific American custom media and Immunomic Therapeutics released an article titled, “The Fight Against Cancer is Increasingly Personal,” by reclassifying tumors, scientists are finding a path to genuine cancer cures.

Immuno-Oncology Panel led by Scientific American February 12, 2018 07:30 AM Eastern Standard Time   ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics (ITI), pioneering the study of investigational LAMP-based nucleic acid immunotherapy programs,

January 23, 2018 11:24 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Tomorrow, Immunomic Therapeutics, Inc. Senior Director of Corporate Development Sia Anagnostou will present at Phacilitate’s Immuno-Oncology Frontiers World in Miami.

December 13, 2017 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, is pleased to welcome Drew Pardoll, MD, Ph.D., Director of

Cancer Vaccination Approach Incorporates Immunomic Therapeutics' LAMP-Vax Technology with CMV Technology November 22, 2017 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Last week results from a study conducted by investigators

Presentation to Examine the Potential of LAMP Enhancing Antitumor Immunity November 13, 2017 07:30 AM Eastern Standard Time ROCKVILLE, Md.--(BUSINESS WIRE)--Tomorrow, Immunomic Therapeutics, Inc. scientist, Dr. Pratima Sinha, will present

Sia Anagnostou, Senior Director at Immunomic Therapeutics authored this article, "Md. is developing the next generation of life-saving vaccines" in the Baltimore Sun. http://www.baltimoresun.com/news/opinion/oped/bs-ed-op-1020-vaccines-md-20171018-story.html  

Congratulations to our scientific advisory board member, Dr. John Sampson, for being named to the National Academy of Medicine http://www.dukecancerinstitute.org/news/sampson-named-national-academy-medicine